How Much Private Equity Is Paying for Veterinary Practices

You can have a profitable clinic and a full appointment book and still find yourself in the dark when wondering how much private equity is paying for veterinary practices like yours. Many owners hear numbers tossed around 6x, 8x, and even 12x, but few understand what determines those multiples.

In today’s market, clinics with 4-7 DVMs, clean accrual-basis books, and strong staff continuity are seeing sale prices well above those of owner-operated practices, even when the revenue appears similar on paper. That’s because private equity buyers are evaluating risk and replicability, in addition to profit. 

This blog explores what private equity firms look for, what sellers commonly get wrong, and how to approach the process with leverage.

How Much Private Equity Is Paying for Veterinary Practices?

Private equity firms are paying between 4x and 15x adjusted EBITDA for veterinary practices. The valuation depends on the number of full-time DVMs, your level of involvement in day-to-day operations, and the strength of your financial documentation.

Multiples aren’t set by revenue size but more by risk. PE groups price based on what they’ll inherit post-sale. Often, a reliable team, verified earnings, and systems that don’t need rebuilding. 

A clinic with 4 – 6 doctors, 22%+ EBITDA margins, and a proper lease structure is a different deal entirely from a solo DVM model with high dependency and weak reporting.

How Private Equity Prices Veterinary Clinics Today

Clinic Profile	DVMs	EBITDA Margin	Typical Multiple
Solo DVM, owner-reliant	1	Below 15%	4x – 6x
2 – 3 DVMs, shared production	2–3	15 – 18%	6x – 8x
4 – 7 DVMs, delegated operations	4–7	18 – 22%+	9x – 15x

Note: Multiples above 12x usually require excellent financials, minimal transition risk, and stable staffing.

What Increases the Multiple

Multiples don’t just depend on performance but on how repeatable and transferable that performance is without the seller.

Here’s what consistently pushes valuations toward the top of the range.

Checklist: What Increases Your Valuation Multiple

• Clean, accrual-basis financials (2 – 3 years minimum)
• Consistent, stable EBITDA (no sudden upticks or recent jumps)
• Normalized financials with legitimate, defensible add-backs
• Low owner reliance: clinical, operational, and managerial
• Long-term lease in place (or NNN if the seller owns the property)
• Multi-DVM team with clear roles and low turnover
• Delegated operations with a practice manager or medical lead
• SOPs, org charts, compensation bands, all documented
• High-quality earnings: 22%+ EBITDA, normalized and fair

Typical Multiples Based on DVM Count (Not Practice Type)

Clinic Profile	DVMs	Typical Multiple
Solo	1	4x – 6x
Small Vet Practices	2 – 3	6x – 8x
Mid-Large Vet Practices	4 – 7	9x – 15x

Note: Outliers do exist, but they’re rarely speculative. To justify the high end of any range, buyers expect:

• Margin quality (22%+ EBITDA)
• Clear delegation across DVMs
• Full documentation during diligence
• Multi-year lease or attractive property handoff
• No single point of failure (i.e., not reliant on one DVM or leader)

What Private Equity Buyers Are Looking For

Private equity is not a monolith. Though some groups build national platforms, most are focused solely on tuck-in deals. What connects them is a shared approach to evaluating veterinary practices. They pay for transferable cash flow, proper documentation, and a team that isn’t walking the day the seller leaves.

Two Types of PE Behavior

• Platform buyers look for larger clinics with 4 – 6+ DVMs, high-margin EBITDA (18-22%), and a leadership team already in place.
  
• Add-on buyers want smaller practices that are stable and easy to absorb into an existing structure, with minimal staff disruption.

If a clinic can’t run without the owner, private equity doesn’t see a business; they see a liability. What they’re buying isn’t the seller’s reputation but a structure that remains intact after the handoff. If they need to rebuild leadership, renegotiate leases, or replace your production, the multiple drops fast.

• The first thing they check is financial reliability. Clinics with clean, normalized EBITDA and accrual-based reporting attract interest. However, numbers alone don’t close a deal. They need to see if those numbers can be sustained.
  
  For example, if your EBITDA margin is between 18% and 22%, that’s promising, but only if it wasn’t propped up by deferred expenses or one-time adjustments.
  
  
• The second thing they check for is your team. A five-DVM clinic with low turnover and a manager who handles operations signals continuity. That’s worth more than a higher-revenue clinic where one person still signs every check, fills every schedule, and produces 70% of revenue.

Equally important is the leadership structure. Practices where the owner makes all hiring decisions, reviews every invoice, and solves every clinical issue are hard to price with confidence. Buyers want to know: Who will keep the team aligned post-close? If the answer is unclear, the multiple choice reflects that uncertainty.

That’s why many clinics that look strong on paper fall short in diligence. A practice might show good numbers but lack the depth buyers need to justify paying at the top of the veterinary industry acquisition benchmarks.

Here’s a quick summary of what PE buyers want:

What PE Buyers Want
Margin over volume. 22% EBITDA on $2M revenue is worth more than 10% on $3M.  Buyers ask who’s staying, what they do, and if they’ve been incentivized to remain.  Stability at handover. They price based on what happens after you’re out of the picture.

What Private Equity Buyers Don’t Want to See

Many clinic owners prepare for a valuation by cleaning up their revenue and tightening expense lines, but overlook the structural issues that quietly deter buyers. When a private equity firm lowers its offer or backs out entirely, it’s rarely because of revenue. It’s because of risks that can’t be managed after closing.

• The first red flag is financial inconsistency. If your books are cash-based, if your EBITDA jumps suddenly in the 6- to 12-month period before listing, or if you can’t justify your add-backs with documentation, buyers tend to hesitate. Besides the number, they want to see how it was built.
  
• The next most common red flag is owner-centered production. If you’re still responsible for 60-80% of revenue, there’s no safety net for the buyer. A new owner would either need to replace your output quickly or suffer a revenue drop, which is both expensive and risky. PE buyers prefer production that’s shared across a multi-DVM team, with minimal disruption if the seller exits.
  
• The third red flag is staff instability. If you’ve had two associates leave in the last year, or if key team members don’t plan to stay after the sale, private equity buyers assume revenue will decline. It doesn’t matter if you’ve replaced them, but buyers price based on what’s reliable, not what’s new.

Above all, they also look at real estate. If the lease is month-to-month, has no renewal terms, or if the rent is higher than the market rate, buyers see that as volatility. Even if the vet practice is healthy, a bad facility deal can impact the overall offer.

Here’s a quick summary of what PE buyers don’t want:

What PE Buyers Don’t Want
High owner dependency (e.g., 1 DVM producing 80%+ of revenue)  Unverified financials or missing accrual-based documentation  Staff risk, especially if turnover has been high or key roles aren’t determined

How Private Equity Thinks About Risk vs. Return

When private equity looks at a veterinary practice, the first question isn’t “How big is the revenue?” Instead, it’s “How likely is this to break after the owner steps away?”

That’s why higher multiples aren’t tied to size but to how safe the investment feels. Buyers don’t price for best-case scenarios. They calculate the downside first, then decide what they’re willing to pay based on how confident they are.

Let’s understand this with an example. 

Consider two veterinary practices, both showing $600K in adjusted EBITDA. One sells for $3 million and the other for $ 7.2 million. 

Why? 

Private equity doesn’t value clinics on raw earnings. They value how repeatable and transferable EBITDA is. The multiple is a direct reflection of the risk the buyer must absorb post-close.

Here’s how that plays out:

	Clinic A	Clinic B
DVM Count	1 (owner-producer)	5 DVMs, distributed production
Staff Turnover	Recent departures, no retention plan	Tenure 4 – 6 years, retention incentives
Financial Records	Cash-based, minimal reconciliation	Accrual-based, fully normalized
SOPs and Systems	Verbal, owner-dependent	Documented, manager-led operations
Lease	1-year rolling, no renewal clause	7-year NNN with renewal terms
Multiple Offered	5.0x EBITDA ($3M)	12.0x EBITDA ($7.2M)

Private equity buyers consider the hold period (typically 3-7 years) and the potential next sale. They need to know if the practice will hold its earnings, retain staff, and operate with minimal hands-on involvement. 

If those factors are missing, even concrete numbers won’t carry weight. This risk-return equation is consistent across all buyer types, but private equity (PE) is exceptionally disciplined. If they sense the clinic’s earnings can’t survive without the seller, the deal either delays or gets repriced heavily.

Is Private Equity the Right Fit for Your Clinic?

Private equity isn’t for everyone. These groups are highly selective and work best when the clinic already runs with low friction and clear leadership. If your clinic relies heavily on you, or you’re aiming for a clean exit, the structure and expectations of PE may be a mismatch.

Suppose you’ve built a clinic that can operate independently, with a stable team and leadership that extends beyond your name. In that case, PE can offer a premium price and possibly an opportunity to stay involved as a co-owner or Medical Director.

On the other hand, if you’re looking for a fast exit, value full autonomy, or run a smaller practice, a private or associate buyer may be the more natural fit. These buyers typically allow for more flexibility in deal structure, less oversight, and greater continuity for how the clinic runs.

Here’s how the fit typically plays out:

Best Fit for PE	May Be Better with a Private Buyer
4 – 6 DVMs with EBITDA of $700K or more	1 – 2 DVMs generating under $500K EBITDA
Delegated leadership (e.g., clinic manager)	The owner is the sole decision-maker
Staff retention plan already in place	High turnover or no succession planning
Seller willing to stay post-sale (1–3 yrs)	Seller seeking full exit with minimal handover
Clean lease and scalable systems	Informal systems, short leases, high owner role

The real deciding factors are your personal goals:

• Earn-Outs: Common in PE deals to offset risk. You may not receive the full value upfront.
  
• Decision-Making: You won’t have final say anymore. PE often takes over operations post-handover.
  
• Culture Fit: PE buyers prioritize returns. If your practice’s culture is deeply tied to your leadership style, that shift may be difficult for your team.

What Happens After the Sale?

After a private equity deal closes, your title may stay the same, but your reality changes fast. Most PE-backed deals include a 12 – 24-month transition period, during which the former owner remains involved as a Medical Director or team lead. 

You’ll likely no longer run payroll or manage marketing, but you’ll be expected to lead clinically, maintain culture, and help stabilize revenue.

Here’s what typically changes post-sale:

• Your Role: You shift from clinic owner to salaried clinical lead. Some sellers like the reduced pressure, whereas others struggle with the lack of final say.
  
• Staffing Stability: Most PE buyers aim to keep your team intact. Turnover is expensive. But roles may be clarified, and underperformers may not last long.
  
• Earn-Outs & Targets: If your deal included performance-based earn-outs, you’ll be tracking revenue, margin, and sometimes staff retention. Missing targets can delay or reduce future payouts.
  
• Reporting: PE firms operate on monthly dashboards. Expect structured reporting, reviews with regional managers, and scheduled growth plans.

How to Prepare If You Want PE to Pay More

To secure the top end of your EBITDA multiple, preparation needs to begin well before the practice hits the market.

Start 12 – 18 months in advance. This gives time to normalize your numbers, correct weak spots, and ensure the practice looks good with earnings.

Here’s a prep checklist built around what private equity platforms value:

1. Fix the Financial Story

• Move to accrual accounting (if you haven’t already)
• Justify add-backs with documentation (salary, personal expenses, one-offs)
• Clean up any inconsistencies in revenue patterns or margins

2. Real Estate Shouldn’t Be a Blocker

• Secure a long-term lease or prep for a clean sale/leaseback
• Remove renewal ambiguity because buyers want clarity, not surprises

3. Create a Staff-Driven Operation

• Appoint a clinical lead who isn’t the owner
• Cross-train key roles and document all workflows

4. Compile Diligence Materials Now

• Last 3 years’ financials (P&L, balance sheets, tax returns)
• Employment contracts, equipment list, vendor agreements
• SOPs for medicine, HR, and client flow

5. Taper Your Role

• Reduce your production gradually
• Stop being the sole decision-maker

Conclusion

Private equity is ideal for vet clinic owners with mid-to-large teams, a reliable EBITDA, a defined structure, and the willingness to support a transition. That said, the gap between a 5x and a 12x multiple is about risk.

Your ability to lower perceived risk through financial clarity, operational depth, and smart positioning will dictate what the buyer sees and what they’re willing to pay. If you’re serious about exploring this path, start the prep now. You don’t get a second chance at a first impression.

FAQs